205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.37%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-66.16%
Negative gross profit growth while ADI is at 0.38%. Joel Greenblatt would examine cost competitiveness or demand decline.
12.50%
EBIT growth below 50% of ADI's 145.27%. Michael Burry would suspect deeper competitive or cost structure issues.
12.50%
Operating income growth under 50% of ADI's 145.27%. Michael Burry would be concerned about deeper cost or sales issues.
3.57%
Net income growth under 50% of ADI's 115.68%. Michael Burry would suspect the firm is falling well behind a key competitor.
-9.17%
Negative EPS growth while ADI is at 111.86%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-9.17%
Negative diluted EPS growth while ADI is at 111.86%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-3.70%
Share reduction while ADI is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-3.70%
Reduced diluted shares while ADI is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
12.88%
Dividend growth of 12.88% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-90.30%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-135.76%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
38.03%
10Y revenue/share CAGR at 50-75% of ADI's 53.45%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
38.03%
5Y revenue/share CAGR at 50-75% of ADI's 53.45%. Martin Whitman would worry about a lagging mid-term growth trajectory.
12.06%
3Y revenue/share CAGR at 50-75% of ADI's 23.63%. Martin Whitman would question if the firm lags behind competitor innovations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-298.66%
Negative 10Y net income/share CAGR while ADI is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-298.66%
Negative 5Y net income/share CAGR while ADI is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-163.05%
Negative 3Y CAGR while ADI is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.37%
3Y dividend/share CAGR of 76.37% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-5.93%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
2.82%
Inventory growth well above ADI's 0.65%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.20%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
0.63%
75-90% of ADI's 0.76%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
18.67%
Debt growth far above ADI's 13.92%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-7.20%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.